Essayer OR - Gratuit
Why a ₹1-crore health cover matters—and how to buy it
Mint Hyderabad
|June 13, 2025
What to watch out for while upgrading your health insurance policy amid rising medical cost
In 2016, Hyderabad-based Ankur Pathak's mother-in-law was diagnosed with Stage-III ovarian cancer, barely a month or two after undergoing angioplasty. The back-to-back medical emergencies left the family with limited funds to manage the treatment costs.
Though she had a reimbursement-based government health cover, the procedural delay and out-of-pocket expenses proved overwhelming. She passed away within three months, unable to continue chemotherapy.
The experience made Pathak realize the importance of having a strong insurance cover with adequate immediate support, regardless of employer-provided plans. He opted for ₹50 lakh base coverage, which would increase to ₹1 crore with no-claim bonuses.
More Indians are opting for ₹1-crore health covers as medical costs rise. Online insurance platform Policybazaar saw the number of such policies surge to 9,739 in 2024 from 4,427 policies in 2023. "In 2025, we've already sold 7,521 such policies by May," said Siddharth Singhal, health insurance head at Policybazaar, noting an 85% growth expectation for the year.
Why ₹1 crore?
Insurance advisors say ₹1 crore may feel excessive today, but five to 10 years down the line, it could be just about right. Medical inflation is pushing costs up fast. Data from the surgery-care company Hexa Health showed that the average severe illness claim in India doubles every 10 years.
For example, cancer treatment costs that hovered around ₹2-3 lakh in 2015 now average ₹4-6 lakh, and could touch ₹9 lakh by 2035. Meanwhile, a heart bypass that cost ₹3 lakh a decade ago may cost over ₹6 lakh by 2035.
While average treatment costs for severe illnesses provide a baseline, actual expenses often run significantly higher, especially in private hospitals and metro cities, where charges can be 2-3X the national average.
Additionally, illnesses rarely occur in isolation; follow-up treatments, diagnostics, and medications add recurring costs over time.
Cette histoire est tirée de l'édition June 13, 2025 de Mint Hyderabad.
Abonnez-vous à Magzter GOLD pour accéder à des milliers d'histoires premium sélectionnées et à plus de 9 000 magazines et journaux.
Déjà abonné ? Se connecter
PLUS D'HISTOIRES DE Mint Hyderabad
Mint Hyderabad
Do tariffs work?
With trade tensions between the US and China flaring up again, the spotlight is on how their game of mutually assured disruption plays out.
1 min
October 22, 2025

Mint Hyderabad
Keppel buys 49% in Cleantech, takes control
cation,” a Shell spokesperson said in an emailed response.
1 mins
October 22, 2025
Mint Hyderabad
CCI clears Torrent's JB stake buy proposal
Fair trade regulator Competition Commission of India (CCI) on Tuesday cleared Torrent Pharmaceuticals Ltd's proposed acquisition of a stake in JB Chemicals and Pharmaceuticals, subject to voluntary modifications offered by the companies.
1 min
October 22, 2025
Mint Hyderabad
'Balanced India-US portfolios fared better'
Saurabh Mukherjea has a simple message for investors in Indian equities: it's time to look beyond. The chief investment officer and co-founder of Marcellus Investment Managers believes that with jobs in India drying up due to the US tariffs, consumption slowdown and tepid corporate earnings, it “will be tough for a market already trading at record-high valuations to move any further”.
2 mins
October 22, 2025

Mint Hyderabad
NITI Aayog proposes new panel to supercharge net-zero push
India’s top government think-tank has called for setting up a panel to guide policy and coordinate multi-ministry efforts on climate action and energy transition, two people aware of the development said.
1 mins
October 22, 2025

Mint Hyderabad
The Jio tariff hike everyone expected isn't coming—yet
The company has instead chosen to grow revenue by driving users to consume more data
2 mins
October 22, 2025
Mint Hyderabad
Reliance seeks to buy Middle East oil
Reliance Industries Ltd bought Middle Eastern crudes last week and may place more orders, ina sign that Western pressure against Russian flows may be starting to impact its procurement patterns.
1 min
October 22, 2025
Mint Hyderabad
Deloitte's AI debacle in Australia isa warning for all early adopters
That a report riddled with AI hallucinations was sent to a government should be a wake-up call
3 mins
October 22, 2025
Mint Hyderabad
Jio-BP’s Q2 petrol, diesel sales up 34%
Jio-BP, the fuel retailing joint venture of Reliance Industries and super major BP, clocked a 34% rise in petrol and diesel sales in the September quarter as the joint venture aggressively expands its retail network.
1 min
October 22, 2025
Mint Hyderabad
Recent Nobel prizes for economics seem rich in irony
This year’s Sveriges Riksbank Prize in Economic Sciences in Memory of Alfred Nobel was awarded “for having explained innovation-driven economic growth,” with one half to Joel Mokyr “for having identified the prerequisites for sustained growth through technological progress” and the other half jointly to Philippe Aghion and Peter Howitt “for the theory of sustained growth through creative destruction.”
3 mins
October 22, 2025
Listen
Translate
Change font size